Behavioral Health Business April 9, 2024
Pharma giant Otsuka (OTCMKTS:OTSKY) is teaming up with Alphabet’s life science subsidiary Verily to launch a new longitudinal study to research depression and mental health.
The study, called My Mental Health Journey, will use Verily’s technology to collect real-world data from individuals living with depression and mental health disorders. The goal of the research is to better understand mental health conditions across time and in a real-world setting.
“The registry will also generate retrospective and prospective data to drive insights that will power and improve future research,” Dr. John Kraus, executive vice president and chief medical officer at Otsuka, told Behavioral Health Business in an email. “This includes future trial design, site selection, publications, and outcomes research. Additionally, core data...
Today's Sponsors
Today's Sponsor